These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7365386)

  • 1. Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously.
    Farmer JH; Kodell RL; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):55-68. PubMed ID: 7365386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA adduct formation during continuous feeding of 2-acetylaminofluorene at multiple concentrations.
    Beland FA; Fullerton NF; Kinouchi T; Poirier MC
    IARC Sci Publ; 1988; (89):175-80. PubMed ID: 3198200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of distributions of time to appearance of tumor and time to death from tumor after appearance in mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Greenman DL; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):89-102. PubMed ID: 7365388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dose and time in a long-term, low-dose carcinogenic study.
    Littlefield NA; Farmer JH; Gaylor DW; Sheldon WG
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):17-34. PubMed ID: 7365379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of life-shortening effects in female BALB/C mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Littlefield NA; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):69-87. PubMed ID: 7365387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic and morphologic characteristics of urinary bladder neoplasms induced in BALB/c female mice with 2-acetylaminofluorene.
    Frith CH; Farmer JH; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):103-19. PubMed ID: 7365375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
    Crump KS; Clewell HJ
    Toxicol Sci; 2003 Aug; 74(2):485; author reply 485-6. PubMed ID: 12730607
    [No Abstract]   [Full Text] [Related]  

  • 8. Age-dependent responses to 2-acetylaminofluorene in BALB/c female mice.
    Greenman DL; Boothe A; Kodell R
    J Toxicol Environ Health; 1987; 22(2):113-29. PubMed ID: 3669095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of continuous and discontinued exposure to 2-AAF on urinary bladder hyperplasia and neoplasia.
    Littlefield NA; Greenman DL; Farmer JH; Sheldon WG
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):35-54. PubMed ID: 7365385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-examination of the ED01 study--risk assessment using time.
    Fundam Appl Toxicol; 1981; 1(1):88-123. PubMed ID: 7184778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary bladder neoplasms induced in BALB/c female mice with low doses of 2-acetylaminofluorene.
    Gaylor DW; Greenman DL; Frith CH
    J Environ Pathol Toxicol Oncol; 1985; 6(1):127-36. PubMed ID: 4067830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thresholds of carcinogenicity in the ED01 study.
    Andersen ME; Conolly RB; Gaylor DW
    Toxicol Sci; 2003 Aug; 74(2):486-7; author reply 487-8. PubMed ID: 12874369
    [No Abstract]   [Full Text] [Related]  

  • 13. The ED01 study: summary and conclusions.
    Gaylor DW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):179-83. PubMed ID: 7365380
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between spontaneous and experimentally induced tumors in female BALB/c mice in a large 2-acetylaminofluorene study.
    Shinohara Y; Frith CH
    J Environ Pathol Toxicol Oncol; 1986; 6(5-6):85-95. PubMed ID: 3783444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorene.
    Poirier MC; Fullerton NF; Kinouchi T; Smith BA; Beland FA
    Carcinogenesis; 1991 May; 12(5):895-900. PubMed ID: 2029755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic dose-response studies in mice fed 2-AAF.
    Littlefield NA; Cueto C; Davis AK; Medlock K
    J Toxicol Environ Health; 1975 Sep; 1(1):25-37. PubMed ID: 1185817
    [No Abstract]   [Full Text] [Related]  

  • 17. Re-examination of the ED01 study. Overview.
    Fundam Appl Toxicol; 1981; 1(1):28-63. PubMed ID: 7184773
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of continued versus discontinued administration of 2-acetylaminofluorene on the morphology and behavior of hepatocellular and urinary bladder tumors in mice.
    Frith CH; Kodell RL; Farmer JH
    J Environ Pathol Toxicol Oncol; 1986; 7(1-2):17-23. PubMed ID: 3795011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study.
    Cohen SM; Ellwein LB
    Toxicol Appl Pharmacol; 1990 Jun; 104(1):79-93. PubMed ID: 2360210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of total dose and dose rate in carcinogenicity studies.
    Littlefield NA; Gaylor DW
    J Toxicol Environ Health; 1985; 15(5):545-50. PubMed ID: 4046064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.